Safety of intravenous terbutaline in acute severe asthma: A retrospective study

Acta Paediatrica, International Journal of Paediatrics

Volumn 94, Issue 9, 2005, Pages 1214-1217

  Kambalapalli, Mamatha ^a,b   Nichani, S ^a   Upadhyayula, S ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

Arrhythmias; Asthma; Hypokalaemia; Inotropic; Terbutaline

Indexed keywords

POTASSIUM; TERBUTALINE;

ADOLESCENT; ARTICLE; ASTHMA; BLOOD PRESSURE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROCARDIOGRAM; ELECTROLYTE BLOOD LEVEL; EVALUATION; FEMALE; HEART RATE; HOSPITAL ADMISSION; HUMAN; HYPOKALEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PNEUMOTHORAX; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UNITED KINGDOM;

EID: 27144451258     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2005.tb02077.x     Document Type: Article

References (17)

1. National Asthma Campaign-Asthma Audit 2002. J Asthma 2002;8 Suppl; p. 1.
2. Silverman M. Definition and epidemiology of asthma. In: Campbell AGM, McIntosh N, editors. Text book of paediatrics. 5th ed. Edinburgh: Churchill Livingstone; 1998. p. 536.
3. Anonymous authors. Oxygen, beta2-agonists and corticosteroids-the back bone of treatment for acute severe asthma in hospitalised children. Drugs and Therapy Perspectives 2002;18:10-3.
4. Smyth RL. Asthma: A major paediatric health issue. Respir Res 2002;3 Suppl 1:S3-7.
5. British Guideline on the Management of Asthma. Thorax 2003;58 Suppl 1:1-83.
6. Maguire JF, O'Rourke P, Colan SD, Geha RS, Crone R. Cardiotoxicity during treatment of severe childhood asthma. Pediatrics 1991;88:1180-6.
7. De Nicola LK, Gayle MO, Blake KV. Drug therapy approaches in treatment of acute severe asthma in hospitalised children. Paediatr Drugs 2001;3:509-37.
8. O'Connell MB, Iber C. Continuous intravenous terbutaline infusions for adult patients with status asthmaticus. Ann Allergy 1990;64(2pt2):213-8.
9. Van Renterghem D, Lamont H, Elinck W, Pauwels R, Vanderstraeten M. Intravenous versus nebulised terbutaline in patients with acute severe asthma; a double-blinded randomised study. Ann Allergy 1987;59:313-6.
10. Nair SJ, Cloutier MM. Managing severe asthma exacerbations in children. J Respir Dis 2003;5:12-21.
11. Seratin WE. Drugs used in the treatment of asthma. In: Hardman JG, Gilman AG, Limbird LE, editors. The pharmacological basis of therapeutics. 9th ed. McGraw-Hill; 1996.
12. Travers A, Jones AP, Kelly K, Barker SJ, Camargo CA Jr, Rowe BH. Intravenous beta 2-agonists for acute asthma in the emergency department (Cochrane Review). In: The Cochrane Library, Issue 3, 2003. Oxford: Update Software.
13. Richard JS, Eron YF. Beta2-agonists in acute asthma: The evolving state of art. Pediatr Emerg Care 2002;8:442-7.
14. Chiang VW, Burns JP, Rifai N, Lipshultz SE, Adams MJ, Weiner DL. Cardiac toxicity of intravenous terbutaline for the treatment of severe asthma in children: A prospective assessment. J Pediatr 2000;137:73-7.
15. Fuglsang G, Pedersen S, Borgstrom L. Dose-response relationships of intravenously administered terbutaline in children with asthma. J Pediatr 1989;114:315-20.
16. Stephanopoulos DE, Monge R, Schell KH, Wyckoff P, Peterson BM. Continuous intravenous terbutaline for paediatric status asthmaticus. Crit Care Med 1998;26:1744-8.
17. Braden GL, Von Oeyen PT, Germain MJ, Watson DJ, Haag BL. Ritodrine and terbutaline induced hypokalemia in preterm labor: Mechanisms and consequences. Kidney Int 1997;51:1867-75.